De Pascale, Gennaro
 Distribuzione geografica
Continente #
EU - Europa 3.674
NA - Nord America 3.284
AS - Asia 896
SA - Sud America 46
AF - Africa 20
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.943
Nazione #
US - Stati Uniti d'America 3.257
DE - Germania 1.065
SE - Svezia 671
IT - Italia 645
CN - Cina 485
PL - Polonia 245
UA - Ucraina 222
IE - Irlanda 217
FR - Francia 193
GB - Regno Unito 128
SG - Singapore 124
TR - Turchia 103
FI - Finlandia 82
IN - India 73
RU - Federazione Russa 67
HK - Hong Kong 29
BE - Belgio 26
IR - Iran 23
CA - Canada 18
AU - Australia 16
ES - Italia 15
NL - Olanda 15
CH - Svizzera 14
BR - Brasile 13
CO - Colombia 13
CZ - Repubblica Ceca 13
JP - Giappone 13
KR - Corea 12
VN - Vietnam 9
AR - Argentina 8
MX - Messico 8
CI - Costa d'Avorio 7
GR - Grecia 7
AT - Austria 6
CL - Cile 6
EG - Egitto 6
EU - Europa 6
MK - Macedonia 6
RO - Romania 6
BG - Bulgaria 5
EE - Estonia 5
TW - Taiwan 5
VA - Santa Sede (Città del Vaticano) 5
PE - Perù 4
PH - Filippine 4
RS - Serbia 4
IL - Israele 3
NO - Norvegia 3
PT - Portogallo 3
AF - Afghanistan, Repubblica islamica di 2
KZ - Kazakistan 2
MU - Mauritius 2
NG - Nigeria 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CM - Camerun 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 7.943
Città #
Chandler 702
Ashburn 246
Dublin 216
Warsaw 210
Jacksonville 153
Ann Arbor 140
San Mateo 128
Nanjing 126
New York 117
Milan 103
Wilmington 89
Rome 86
Chicago 83
Dearborn 82
Fairfield 82
Nürnberg 80
Woodbridge 80
Singapore 73
Seattle 69
Boston 64
Marseille 63
Izmir 62
Houston 61
Cattolica 54
Moscow 51
Beijing 50
Redwood City 49
Nanchang 48
Princeton 46
Lawrence 39
Munich 38
Helsinki 32
Kraków 30
Bremen 29
Kunming 28
Boardman 27
Cambridge 27
Los Angeles 24
Redmond 23
Hangzhou 22
Brussels 21
Augusta 20
Norwalk 20
Padova 20
Hong Kong 19
Pune 19
Hebei 18
Lancaster 18
Mountain View 18
Tianjin 18
Kocaeli 17
London 15
Shenyang 15
University Park 15
Guangzhou 13
Jiaxing 13
Kish 13
Washington 13
Changsha 12
San Diego 12
Verona 12
Brno 11
Falls Church 11
Leawood 11
Turin 11
Zhengzhou 10
Busto Arsizio 8
Hefei 8
Seoul 8
Zurich 8
Abidjan 7
Andover 7
Fremont 7
Renton 7
Shanghai 7
Brooklyn 6
Buenos Aires 6
Detroit 6
Jinan 6
Lanzhou 6
Ottawa 6
Shawnee 6
Bologna 5
Clusone 5
Dong Ket 5
Edinburgh 5
Ferrara 5
Florence 5
Istanbul 5
Lappeenranta 5
Monmouth Junction 5
Paris 5
Philadelphia 5
Santiago 5
Simi Valley 5
Sofia 5
Torino 5
Toronto 5
Vienna 5
Arzano 4
Totale 4.325
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 307
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 232
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 212
Colistin use in critically ill patients: in search of the optimal dosing. 204
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 195
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 178
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 166
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 159
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 152
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 148
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 135
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 134
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 132
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 129
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 128
Neurological involvement during legionellosis, look beyond the lung 119
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 116
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 112
Data on the application of early coagulation support protocol in the management of major trauma patients 112
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 110
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 109
The importance of airway and lung microbiome in the critically ill 108
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 103
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 101
Neurological involvement during Legionellosis, look beyond the lung 99
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 99
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 97
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 96
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 96
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 93
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 91
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 87
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 85
Noninvasive ventilation for the immunocompromised patient: always appropriate? 85
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 84
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 81
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 81
Aerosolized colistin cost-effectiveness. Response 79
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 78
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 78
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 75
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 73
Lice, rodents, and many hopes: a rare disease in a young refugee 73
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 72
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 72
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 72
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 72
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 70
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 69
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 69
Sarilumab use in severe SARS-CoV-2 pneumonia 68
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 67
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 67
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 65
Dose of colistin: a work in progress? 65
Fungal infections in the ICU: advances in treatment and diagnosis 63
The place of dexmedetomidine light sedation in patients with acute brain injury 63
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 63
Response 62
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough! 62
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 62
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 62
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 57
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 55
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 55
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 55
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 53
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 52
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 51
Hemadsorption 49
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 49
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study 48
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 48
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 47
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 46
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 44
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 44
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 43
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 43
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 42
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia 42
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 41
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study 40
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 38
Lung Recruitability and Positive End-Expiratory Pressure Setting in ARDS Caused by COVID-19 38
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 37
How to manage aspergillosis in non-neutropenic intensive care unit patients 37
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 36
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 36
Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia 34
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 31
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 30
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 28
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 24
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 23
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 21
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 21
Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors 21
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 20
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial 18
Totale 7.993
Categoria #
all - tutte 30.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.050 168 90 83 69 88 110 102 42 78 59 95 66
2020/2021798 37 68 23 54 81 64 103 31 98 54 135 50
2021/20221.092 90 73 67 68 84 57 24 162 59 71 163 174
2022/20232.120 228 264 134 287 143 233 105 201 246 107 108 64
2023/20241.330 78 274 63 58 67 195 96 93 40 74 140 152
2024/202561 61 0 0 0 0 0 0 0 0 0 0 0
Totale 8.083